STATE OF WISCONSIN INVESTMENT BOARD - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 121 filers reported holding SUTRO BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is 2.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE OF WISCONSIN INVESTMENT BOARD ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$402,520
-34.8%
116,000
-12.6%
0.00%
-50.0%
Q2 2023$617,055
+11.8%
132,700
+11.0%
0.00%0.0%
Q1 2023$552,090
-38.4%
119,500
+7.8%
0.00%
-33.3%
Q4 2022$896,072
+27.3%
110,900
-12.5%
0.00%
+50.0%
Q3 2022$704,000
-15.5%
126,758
-20.8%
0.00%0.0%
Q2 2022$833,000
-12.0%
159,966
+38.8%
0.00%0.0%
Q1 2022$947,000
+13.4%
115,230
+105.3%
0.00%0.0%
Q4 2021$835,000
-21.2%
56,1300.0%0.00%0.0%
Q3 2021$1,060,000
+1.6%
56,1300.0%0.00%0.0%
Q2 2021$1,043,000
+25.8%
56,130
+54.1%
0.00%0.0%
Q1 2021$829,000
+4.8%
36,4300.0%0.00%0.0%
Q4 2020$791,000
+189.7%
36,430
+34.3%
0.00%
+100.0%
Q3 2020$273,000
+110.0%
27,130
+61.5%
0.00%
Q2 2020$130,000
-24.0%
16,8000.0%0.00%
-100.0%
Q1 2020$171,000
-4.5%
16,800
+3.1%
0.00%
Q4 2019$179,000
+20.9%
16,3000.0%0.00%
Q3 2019$148,00016,3000.00%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,824,542$39,611,00019.08%
Samsara BioCapital, LLC 1,675,579$36,377,0003.66%
SILVERARC CAPITAL MANAGEMENT, LLC 185,000$4,016,0002.33%
Affinity Asset Advisors, LLC 200,000$4,342,0002.30%
Altium Capital Management LP 276,719$6,008,0002.24%
FRAZIER MANAGEMENT LLC 1,001,421$21,741,0001.67%
BVF INC/IL 1,854,162$40,254,0001.58%
Asymmetry Capital Management, L.P. 157,583$3,421,0001.56%
Parkman Healthcare Partners LLC 266,645$5,789,0001.48%
AJU IB Investment Co., Ltd. 175,000$3,799,0001.44%
View complete list of SUTRO BIOPHARMA INC shareholders